Nagase (FRA:P22) Research & Development: €0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:P22 Nagase & Co Ltd FRA:P22
60 GF Score
Price €6.10
GF Value €4.44
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Nagase Research & Development?

Nagase FRA:P22 +1.67% 60 Research & Development is €0 Mil as of Mar. 2026. GuruFocus rates FRA:P22 with a GF Score™ of 60/100 and a GF Value™ of €4.44 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Nagase's Research & Development for the three months ended in Mar. 2026 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0 Mil.

Nagase  (FRA:P22) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Nagase Research & Development Related Terms

Nagase Research & Development Historical Data

* Premium members only.

The historical data trend for Nagase's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nagase Research & Development Chart

Nagase Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Nagase Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:P22
60GF Score
Nagase & Co Ltd FRA:P22
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nagase Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0 Mil mean?
Nagase (FRA:P22) has a Research & Development of €0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Nagase and its competitors.
Is Nagase's Research & Development too high?
Nagase's current Research & Development is €0 Mil. Overall, Nagase has a GF Score™ of 60/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nagase's Research & Development compare to LIN and SHW?
Nagase's Research & Development of €0 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Chemicals company?
A good Research & Development depends on the Chemicals industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Nagase and its competitors. Nagase's current Research & Development is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nagase stock overvalued right now?
Based on GuruFocus' analysis, Nagase (FRA:P22) is currently considered Significantly Overvalued. The stock's GF Value™ is €4.44, compared to a current price of €6.10 — trading 37.4% above its estimated fair value. The current Research & Development is €0 Mil. Nagase's overall GF Score™ is 60/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Nagase (FRA:P22), the current Research & Development is €0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nagase (FRA:P22) Overvalued in 2026?

Based on GuruFocus' analysis, Nagase stock appears to be overvalued. The current stock price of €6.10 is trading 37.4% above its estimated GF Value™ of €4.44. GuruFocus considers Nagase to be Significantly Overvalued.

Key valuation signals for FRA:P22:

  • Research & Development: €0 Mil
  • GF Value™: €4.44 vs. price of €6.10 (37.4% above fair value)
  • GF Score™: 60/100 with 2 warning signs

No single metric tells the full story. See the FRA:P22 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nagase Business Description

Other Exchanges NGSCF:USA8012:Japan
Address 1-1-17 Shinmachi, Nishi-ku, Osaka, JPN, 550-8668
Nagase & Co Ltd is a Japan-based trading company focused on chemicals and related products. The company operates through five segments. The Electronics and Energy segment covers semiconductors, components, AR/VR, renewable energy, and displays. The Functional Material segment handles paints, inks, resins, chemicals, films, and sanitary materials. The Life Related segment offers pharmaceuticals, agrochemicals, food ingredients, cosmetics, reagents, and medical devices. The Mobility segment provides materials and products for batteries, electrification, in-vehicle electronics, and autonomous driving. The Processing Material segment deals with plastics, resins, molding machines, and molds, while Others includes information processing and functional services.
60GF Score

Get the complete analysis for FRA:P22

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.10
Price
€4.44
GF Value